tirzepatide dosing vs semaglutide as Compared with for the Treatment of Obesity switching from tirzepatide to semaglutide

Grzeszczak K, anocha-Arendarczyk N, Malinowski W, Zitek P, Kosik-Bogacka D

Mochi Health has also offered compounded semaglutide during periods of FDA-declared shortage, a practice the FDA has warned consumers about given quality-control risks at some 503A compounding pharmacies [1]

Veterans Study (2026): In a large veterans cohort, SGLT2i showed lower kidney failure risk, but GLP-1 RAs were more protective in moderate-risk (KFRE) patients, while SGLT2i were superior in high-risk patients

This preference shift supports the theory that GLP-1 class medications fundamentally alter food reward processing in the brain, not just hunger signaling

So what led you down that path